Categories: Business

Nephrocare IPO Closes Today: GMP Signals Likely Premium Listing – Last Day To Apply! Here’s Everything You Should Know Before The Opportunity Slips Away

Nephrocare Health IPO closes today, with a price band of ₹438–₹460. Investor sentiment is positive, GMP at ₹20 suggests a likely listing at ₹480. Day 2 subscription stood at 0.37x overall.

Add NewsX As A Trusted Source
Add as a preferred
source on Google
Published by Aishwarya Samant
Published: December 12, 2025 10:17:40 IST

Nephrocare Health IPO Day 3: Last Day To Buy Your Part!

Dialysis care has arrived at Dalal Street! The long-awaited Nephrocare Health Services Ltd. IPO opened for bidding on December 10, and today, December 12, is the last day. All the investors have been watching this health-sector debut very closely, with a price range of ₹438–₹460 per share.

Nephrocare is the largest dialysis network in India, operating under the well-known NephroPlus brand, covering 288 cities in 21 states and 4 union territories.

Are you wondering what all the fuss is about?
The whole market is buzzing, with everyone from retail investors to institutions. You are just one click away to participate in this race. Here are all the details you should look at before clicking the ‘BUY’ button.

Nephrocare Health IPO – Key Details & Subscription Status

Category Details
IPO Size ₹871.05 crore
Fresh Issue 0.77 crore shares (₹353.40 crore)
Offer for Sale (OFS) 1.13 crore shares (₹517.64 crore)
Use of Funds ₹129.1 crore for new dialysis centres
₹136 crore for repayment of borrowings
Balance for general corporate purposes
Minimum Retail Application 32 shares (~₹14,720 at top band)
Allotment Date 15 December 2025
Listing Date 17 December 2025 (BSE & NSE, subject to approvals)
IPO Managers ICICI Securities, Ambit, IIFL Capital, Nomura
Registrar Kfin Technologies Ltd
Subscription Status (Day 2) Overall: 0.37x
Retail: 0.47x
NII: 0.23x
QIBs: 0.29x
Employee Portion: 1.26x
Total Bids Received 49.51 lakh shares against 1.32 crore shares on offer

Nephrocare IPO GMP Today

The investor confidence in Nephrocare Health Services Ltd. is optimistic, and the grey market premium (GMP) has gone up to 20 on December 12 compared to 0 before. This implies there is a high likelihood of a listing price of around 480, which will be a 4.34 percent premium above the price range of the IPO.

(With Inputs)

Also Read: Is ICICI Prudential AMC IPO Worth Investing In? Experts Give Strong ‘Subscribe’ Ratings – Everything You Need to Know

Recent Posts

After Mouni Roy, Mimi Chakraborty Faces Shocking Harassment, Forced Off Stage During Bongaon Event: ‘It Defamed Me’

Bengali actor and MP Mimi Chakraborty faced public harassment during her Bongaon performance when organizers…

January 27, 2026

What Is Bhairav Battalion? Meet Indian Army’s Fastest ‘Invisible Yet Invincible’ Strike Forces Made For Modern ‘Grey-Zone’ Conflicts

The Indian Army unveiled its new Bhairav Battalion during the 77th Republic Day parade, introducing…

January 27, 2026

Is The India-EU Trade Deal Bad News For Trump’s ‘America First’ Strategy? Here’s What The New Pact Means For The US

The India-EU trade deal signals a major shift in global commerce as Trump’s tariff-driven policies…

January 27, 2026